כולבם 250 מג
megapharm ltd - cholic acid - קפסולה קשיחה - cholic acid 250 mg - cholic acid
כולבם 50 מג
megapharm ltd - cholic acid - קפסולה קשיחה - cholic acid 50 mg - cholic acid
טיג'ל ג'ל
rafa laboratories ltd - cetalkonium chloride; choline salicylate - ג'ל - cetalkonium chloride 0.01 %w/w; choline salicylate 8.7 %w/w - choline salicylate - choline salicylate - as an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.
ביבי גאם
rafa laboratories ltd - cetalkonium chloride; choline salicylate - ג'ל - cetalkonium chloride 0.01 %w/w; choline salicylate 8.7 %w/w - choline salicylate - choline salicylate - as an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.
rapid tests+instru.for cholesterol profi
אורטה מדיקל בע"מ - רופא - מיכשור + מגיבים לבדיקות מהירות לפרופיל כולסטרול
פרובוכולין
kamada ltd, israel - methacholine chloride - אבקה להכנת תמיסה לאינהלציה - methacholine chloride 100 mg/vial - for the diagnosis of bronchial airway hyperactivity in subjects who do not have clinically apparent asthma.
סנדאימון ניאורל 50 מג כמוסות
novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.
סנדאימון ניאורל 100 מג כמוסות
novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.
קומירנטי 30 tris
pfizer pharmaceuticals israel ltd - covid-19 mrna vaccine - covid-19 mrna vaccine 0.5 mg/ml - covid-19 vaccines
אוויסטה
eli lilly israel ltd, israel - raloxifene hydrochloride - טבליות מצופות פילם - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - evista is indicated for the treatment of osteoporosis in post menopausal women. evista is indicated for the prevention of osteoporosis in post menopausal women . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.